DaVita HealthCare Partners Inc • DVA

DVA current price
$153.90+44.51%

Capital at risk.

1W
-5.18%
1M
-1.67%
3M
-7.54%
6M
+8.14%
1Y
+44.51%
MAX
+105.48%
About DaVita HealthCare Partners Inc
Ticker
info
DVA
Trading on
info
NYSE
ISIN
info
US23918K1088
Industry
info
Medical Care Facilities
Sector
info
Healthcare
CEO
info
Javier J. Rodriguez
Headquarters
info
2000 16th Street, Denver, CO, United States, 80202
Employees
info
70,000
Website
info
davita.com
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Metrics
BasicAdvanced
Market cap
info
$12.8B
P/E ratio
info
16.75
EPS
info
$9.19
Dividend Yield
info
0.00%
Beta
info
0.89
Forward P/E ratio
info
13.59
EBIDTA
info
$2.66B
Ex dividend date
info
-
Price & volume
Market cap
info
$12.8B
Average daily volume
info
0.7M
90-day return
info
-7.54%
30-day return
info
-1.67%
7-day return
info
-5.18%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
16.75
Forward P/E
info
13.59
PEG ratio
info
1.17
Trailing P/E
info
16.75
Price to sales
info
1.01
Price to book
info
32.98
Earnings
EPS
info
$9.19
EPS estimate (current quarter)
info
$2.73
EPS estimate (next quarter)
info
$2.28
EBITDA
info
$2.66B
Revenues (TTM)
info
$12.7B
Revenues per share (TTM)
info
$145.29
Technicals
Beta
info
0.89
52-week High
info
$169.52
52-week Low
info
$103.40
50-day moving average
info
$158.07
200-day moving average
info
$145.81
Short ratio
info
3.84
Short %
info
8.46%
Management effectiveness
ROE (TTM)
info
44.88%
ROA (TTM)
info
6.94%
Profit margin
info
6.53%
Gross profit margin
info
$3.4B
Operating margin
info
16.28%
Growth
Quarterly earnings growth (YoY)
info
4.60%
Quarterly revenue growth (YoY)
info
4.60%
Share stats
Outstanding Shares
info
82M
Float
info
42.3M
Insiders %
info
48.54%
Institutions %
info
50.22%
Analyst Insights & forecasts
info

23% Buy

55% Hold

22% Sell

Based on information from 9 analysts.

Average price target

info
$156.90
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.62
$1.59
1.89%
Q4 • 23Beat
$2.26
$1.95
15.90%
Q1 • 24Beat
$2.50
$2.54
1.57%
Q2 • 24Beat
$2.50
$2.73
8.42%
Q3 • 24Beat
-
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$3.19B
$223M
6.99%
Q2 • 24
$3.26B
$215M
6.58%
Q3 • 24
2.41%
3.59%
5.86%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$17B
$14.6B
85.76%
Q2 • 24
$17.5B
$15.3B
87.32%
Q3 • 24
2.81%
4.68%
1.82%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$803M
$-162M
$-533M
$678M
Q2 • 24
$810M
$-146M
$-10.9M
$671M
Q3 • 24
0.98%
9.44%
97.96%
0.96%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a DaVita HealthCare Partners Inc share?
Collapse

DaVita HealthCare Partners Inc shares are currently traded for $153.90 per share.

How many shares does DaVita HealthCare Partners Inc have?
Collapse

DaVita HealthCare Partners Inc currently has 82M shares.

Does DaVita HealthCare Partners Inc pay dividends?
Collapse

No, DaVita HealthCare Partners Inc doesn't pay dividends.

What is DaVita HealthCare Partners Inc 52 week high?
Collapse

DaVita HealthCare Partners Inc 52 week high is $169.52.

What is DaVita HealthCare Partners Inc 52 week low?
Collapse

DaVita HealthCare Partners Inc 52 week low is $103.40.

What is the 200-day moving average of DaVita HealthCare Partners Inc?
Collapse

DaVita HealthCare Partners Inc 200-day moving average is $145.81.

Who is DaVita HealthCare Partners Inc CEO?
Collapse

The CEO of DaVita HealthCare Partners Inc is Javier J. Rodriguez.

How many employees DaVita HealthCare Partners Inc has?
Collapse

DaVita HealthCare Partners Inc has 70,000 employees.

What is the market cap of DaVita HealthCare Partners Inc?
Collapse

The market cap of DaVita HealthCare Partners Inc is $12.8B.

What is the P/E of DaVita HealthCare Partners Inc?
Collapse

The current P/E of DaVita HealthCare Partners Inc is 16.75.

What is the EPS of DaVita HealthCare Partners Inc?
Collapse

The EPS of DaVita HealthCare Partners Inc is $9.19.

What is the PEG Ratio of DaVita HealthCare Partners Inc?
Collapse

The PEG Ration of DaVita HealthCare Partners Inc is 1.17.

What do analysts say about DaVita HealthCare Partners Inc?
Collapse

According to the analysts DaVita HealthCare Partners Inc is considered a hold.

DaVita HealthCare Partners Inc news
thumb_up_alt
•Positive
The Best Warren Buffett Stocks to Buy With $1,000 Right Now

Warren Buffett, the longtime head of Berkshire Hathaway (BRK.A 0.99%) (BRK.B 0.95%), has delivered an impressive nearly 20% annualized return for shareholders since 1965, doubling the S&P 500's benchmark return. These exceptional results stem from Buffett and his late partner Charlie Munger's business acumen, combined with Berkshire's ability to strategically invest funds generated by its insurance business.

The Motley Fool•25 Nov 2024, 13:00
thumb_down_alt
•Negative
DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Despite operational success and growth potential, I rate DaVita Inc. a “Hold” due to its high debt, lack of dividend, and current overvaluation. DaVita excels in dialysis services but faces significant risks from debt servicing costs, macroeconomic factors, and potential policy changes. The company's recent financial performance, including a decline in net income and increased debt costs, underscores my conservative valuation approach.

Seeking Alpha•14 Nov 2024, 19:19
thumbs_up_down
•Neutral
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

More than 8,300 people joined the annual event to raise funds for Bridge of Life DENVER , Nov. 12, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced the success of its third annual Move It With Purpose (MIWP) event with more than 8,300 participants, including DaVita teammates, friends, family and key members of the kidney care community. The month-long initiative encourages physical activity — whether it's walking, running, swimming, bicycling or other activities — to benefit Bridge of Life, a nonprofit founded by DaVita to support the prevention and treatment of chronic disease globally.

PRNewsWire•12 Nov 2024, 14:05